The aggregation of amyloid-β 42 (Aβ42) is directly related to the pathogenesis of Alzheimer's disease. Here, we have investigated the early stages of the aggregation process, during which most of the cytotoxic species are formed. Aβ42 aggregation kinetics, characterized by the quantification of Aβ42 monomer consumption, were tracked by real-time solution NMR spectroscopy (RT-NMR) allowing the impact that low-molecular-weight (LMW) inhibitors and modulators exert on the aggregation process to be analysed. Distinct differences in the Aβ42 kinetic profiles were apparent and were further investigated kinetically and structurally by using thioflavin T (ThT) and transmission electron microscopy (TEM), respectively. LMW inhibitors were shown to have a differential impact on early-state aggregation. Insight provided here could direct future therapeutic design based on kinetic profiling of the process of fibril formation.

Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors / Hutchison M.-T.; Bellomo G.; Cherepanov A.; Stirnal E.; Furtig B.; Richter C.; Linhard V.; Gurewitsch E.; Lelli M.; Morgner N.; Schrader T.; Schwalbe H.. - In: CHEMBIOCHEM. - ISSN 1439-4227. - STAMPA. - 24:(2023), pp. e202200760.202200760-e202200760.202200760. [10.1002/cbic.202200760]

Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors

Bellomo G.;Lelli M.;Schwalbe H.
2023

Abstract

The aggregation of amyloid-β 42 (Aβ42) is directly related to the pathogenesis of Alzheimer's disease. Here, we have investigated the early stages of the aggregation process, during which most of the cytotoxic species are formed. Aβ42 aggregation kinetics, characterized by the quantification of Aβ42 monomer consumption, were tracked by real-time solution NMR spectroscopy (RT-NMR) allowing the impact that low-molecular-weight (LMW) inhibitors and modulators exert on the aggregation process to be analysed. Distinct differences in the Aβ42 kinetic profiles were apparent and were further investigated kinetically and structurally by using thioflavin T (ThT) and transmission electron microscopy (TEM), respectively. LMW inhibitors were shown to have a differential impact on early-state aggregation. Insight provided here could direct future therapeutic design based on kinetic profiling of the process of fibril formation.
2023
24
202200760
202200760
Goal 3: Good health and well-being
Hutchison M.-T.; Bellomo G.; Cherepanov A.; Stirnal E.; Furtig B.; Richter C.; Linhard V.; Gurewitsch E.; Lelli M.; Morgner N.; Schrader T.; Schwalbe ...espandi
File in questo prodotto:
File Dimensione Formato  
ChemBioChem - 2023 - Hutchison - Modulation of A 42 Aggregation Kinetics and Pathway by Low‐Molecular‐Weight Inhibitors.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 835.95 kB
Formato Adobe PDF
835.95 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1352737
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact